Clinical Trials Sponsored by S (Sjors) Klompmaker, MD
Total 1 results
-
S (Sjors) Klompmaker, MDCompletedPancreatic Neoplasms | Pancreas Cancer | Pancreas CystNetherlands
Sponsors and Collaborators
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- ProteoSys AG
- Rui-hua Xu, MD, PhD
- Celtaxsys Aus Pty Limited
- AMTC & Associates
- CRMBM-CEMEREM
- Caritas Freetown
- Fondren Orthopedic Group L.L.P.
- Elim Pediatric Pharmaceuticals Inc.
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Societa Italiana di Endoscopia Digestiva
- The Fifth Affiliated Hospital of Zunyi Medical College
- Cardresearch
- Victor Montori
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- Alberta Children's Hospital, Calgary, Canada
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Donders Institute for Brain, Cognition and Behavior
- View Full List
Medical Conditions
- Non-compressible Torso Hemorrhage
- Disturbance of Activity and Attention
- Malignant Ascites Due to Epithelial Carcinoma
- Stereotactic Radioablation for Ventricular Tachycardia
- Prostate Cancer Recurrent
- Auditory Hallucination, Verbal
- Orbital Tumor
- Tube Disorders Eustachian
- Tularaemia
- Postcomatose Unawareness State
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Fever, Sweats, and Hot Flashes
- Fibromyalgia Syndrome, Primary
- Non-dystrophic Myotonias
- Atrial Fibrillation, Postoperative
- Gynecologic Cancer
- Lymphedema of Arm
- Normal Diameter of Optic Nerve
- Spermatogenesis Arrest
- Plasmodium Falciparum Malaria (Drug Resistant)
- View Full List
Drug Interventions
- Flibanserin 100 mg dose every evening
- Lamivudine
- Oxycodone, fentanyl
- Mupirocin Calcium
- Methotrexate
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- SERETIDE Diskus
- Bortezomib/dexamethasone
- Atezolizumab
- Insulin
- Cytarabine ARA-C
- Polyethylene glycol 3350
- Topotecan
- PF-00868554
- Indoximod
- Cetrorelix 78 mg + 78 mg
- Ruxolitinib
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Enzalutamide, Abiraterone
- Epimedium Prenylflavonoids Extract
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in China
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Finland
- Contract Research Organizations in Ghana
- Contract Research Organizations in Kenya
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Oman
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Switzerland
- Contract Research Organizations in United Arab Emirates
- CRO list by country